Bechara A, Casabé A, Chéliz G, Romano S, Fredotovich N
Division Urologia, Hospital Durand, Buenos Aires, Argentina.
J Urol. 1996 Mar;155(3):913-4.
We evaluated the efficacy of 40 micrograms/ml, prostaglandin E1 versus a combination of 17.64 mg./ml. papaverine hydrochloride, 0.58 mg./ml. phentolamine mesylate and 5.8 micrograms/ml. prostaglandin E1 (3-drug mixture).
A total of 32 patients randomly received 1 ml. of either medication by the intracavernous route. All patients had presented with erectile dysfunction longer than 6 months in duration and had failed to respond to high doses of papaverine (60 mg.) plus phentolamine (1 mg).
Of 32 patients 7 (22%) responded to prostaglandin E1 and 16 (50%) to the 3-drug mixture, achieving erections allowing penetration (grade E4 or E5, p < 0.05). Pain was reported by 41% of the patients receiving prostaglandin E1 and 12.5% administered the 3-drug mixture.
The 3-drug mixture may be regarded as more effective than prostaglandin E1 alone in inducing an erectile response with a decreased incidence of pain.
我们评估了40微克/毫升前列腺素E1与17.64毫克/毫升盐酸罂粟碱、0.58毫克/毫升甲磺酸酚妥拉明和5.8微克/毫升前列腺素E1的组合(三药混合物)的疗效。
共有32例患者通过海绵体内途径随机接受1毫升上述两种药物中的一种。所有患者勃起功能障碍持续时间均超过6个月,且对高剂量罂粟碱(60毫克)加酚妥拉明(1毫克)无反应。
32例患者中,7例(22%)对前列腺素E1有反应,16例(50%)对三药混合物有反应,实现了可插入的勃起(E4或E5级,p<0.05)。接受前列腺素E1的患者中有41%报告有疼痛,接受三药混合物的患者中有12.5%报告有疼痛。
在诱导勃起反应方面,三药混合物可能比单独使用前列腺素E1更有效,且疼痛发生率更低。